Previous close | 0.8460 |
Open | 0.8290 |
Bid | 0.7704 x 100 |
Ask | 0.8594 x 100 |
Day's range | 0.7900 - 0.8500 |
52-week range | 0.5390 - 1.3400 |
Volume | |
Avg. volume | 402,233 |
Market cap | 61.299M |
Beta (5Y monthly) | 2.34 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Is it a good or bad thing when a stock experiences a golden cross technical event?
Aligos Therapeutics ( NASDAQ:ALGS ) Full Year 2023 Results Key Financial Results Revenue: US$15.5m (up 12% from FY...
Here is how Aligos Therapeutics, Inc. (ALGS) and Allogene Therapeutics (ALLO) have performed compared to their sector so far this year.